World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
29447
World Ranking
14981
National Ranking
7572

Nicola A. Hanania publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Nicola A. Hanania sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 589 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Nicola A. Hanania D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Nicola A. Hanania sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Nicola A. Hanania is affiliated with Baylor College of Medicine in the United States. Their research primarily focuses on pulmonary and respiratory medicine, with a significant body of work spanning several interconnected disciplines including physiology, immunology, allergy, and surgery.

The scientist's research topics cover a variety of respiratory and immunological areas. Prominent themes include:

  • Asthma and respiratory diseases
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Respiratory Support and Mechanisms
  • Allergic Rhinitis and Sensitization
  • IL-33, ST2, and ILC Pathways

Nicola A. Hanania has contributed to multiple high-impact research papers, notable recent examples include:

  • "Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts," 2023, New England Journal of Medicine
  • "Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma," 2020, Allergy
  • "EAACI Biologicals Guidelines-Recommendations for severe asthma," 2020, Allergy
  • "Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial," 2020, The Lancet Respiratory Medicine
  • "Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022," 2022, MMWR Morbidity and Mortality Weekly Report

Frequent co-authors collaborating with Nicola A. Hanania include:

  • Elizabeth A. Regan
  • Barry J. Make
  • Surya P. Bhatt
  • Edwin K. Silverman
  • Alberto Papi

Hanania has published extensively in prominent venues within the respiratory and allergy fields. These include:

  • CHEST Journal
  • Respiratory Medicine
  • The Journal of Allergy and Clinical Immunology In Practice
  • American Journal of Respiratory and Critical Care Medicine
  • Annals of Allergy Asthma & Immunology

Their publication record covers more than 420 works in medicine, with a core focus on pulmonary and respiratory medicine accounting for over 200 publications. Additional notable contributions include studies in physiology and immunology, supporting advancements in treatment strategies and understanding of respiratory diseases.

Best Publications

  • Lebrikizumab Treatment in Adults with Asthma

    Jonathan Corren;Robert F. Lemanske;Nicola A. Hanania;Phillip E. Korenblat

  • Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

    Amir Qaseem;Timothy J. Wilt;Steven E. Weinberger;Nicola A. Hanania

  • Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.

    Nicola A. Hanania;Sally Wenzel;Karin Rosén;Hsin-Ju Hsieh

  • Anxiety and Depression in COPD: Current Understanding, Unanswered Questions, and Research Needs

    Janet Maurer;Venkata Rebbapragada;Soo Borson;Roger Goldstein

  • Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.

    Nicola A. Hanania;Oral Alpan;Daniel L. Hamilos;John J. Condemi

  • Chronic Obstructive Pulmonary Disease Exacerbations in the COPDGene Study: Associated Radiologic Phenotypes

    MeiLan K. Han;Ella A. Kazerooni;David A. Lynch;Lyrica X. Liu

  • Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

    Nicola A Hanania;Phillip Korenblat;Kenneth R Chapman;Kenneth R Chapman;Eric D Bateman

  • The Efficacy and Safety of Fluticasone Propionate (250 μg)/Salmeterol (50 μg) Combined in the Diskus Inhaler for the Treatment of COPD

    Nicola A. Hanania;Patrick Darken;Donald Horstman;Colin Reisner

  • Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

    Nicola A Hanania;Michael Noonan;Jonathan Corren;Phillip Korenblat

  • Radiation-Induced Lung Injury: Assessment and Management.

    Alexander N. Hanania;Walker Mainwaring;Yohannes T. Ghebre;Nicola A. Hanania

  • Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort.

    Nicola A. Hanania;Hana Müllerova;Nicholas W. Locantore;Jørgen Vestbo;Jørgen Vestbo

  • Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

    Mark T Dransfield;Jean Bourbeau;Paul W Jones;Nicola A Hanania

  • Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications

    D. Robinson;M. Humbert;R. Buhl;A. A. Cruz

  • Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

    Ioana Agache;Jessica Beltran;Cezmi Akdis;Mubeccel Akdis

  • Bronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthma

    Michael E. Wechsler;Michel Laviolette;Adalberto S. Rubin;Jussara Fiterman

  • Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline

    Gerard J. Criner;Jean Bourbeau;Rebecca L. Diekemper;Daniel R. Ouellette

  • Medical Personnel's Knowledge of and Ability to Use Inhaling Devices: Metered-Dose Inhalers, Spacing Chambers, and Breath-actuated Dry Powder Inhalers

    Nicola A. Hanania;Richard Wittman;Steven Kesten;Kenneth R. Chapman

  • Adverse effects of inhaled corticosteroids

    Nicola A. Hanania;Kenneth R. Chapman;Steven Kesten

  • Asthma in the Elderly: Current Understanding and Future Research Needs: A Report of a National Institute on Aging (NIA) Workshop

    Nicola A. Hanania;Monroe J. King;Sidney S. Braman;Carol Saltoun

  • Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease

    Mark T. Dransfield;Mark T. Dransfield;Ken M. Kunisaki;Ken M. Kunisaki;Matthew J. Strand;Antonio Anzueto;Antonio Anzueto

Frequent Co-Authors

Robert A. Wise
Robert A. Wise Johns Hopkins University School of Medicine
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Barry J. Make
Barry J. Make National Jewish Health
MeiLan K. Han
MeiLan K. Han University of Michigan–Ann Arbor
Gerard J. Criner
Gerard J. Criner Temple University
Edwin K. Silverman
Edwin K. Silverman Brigham and Women's Hospital
Russell P. Bowler
Russell P. Bowler Cleveland Clinic
Jeffrey L. Curtis
Jeffrey L. Curtis University of Michigan–Ann Arbor
Nadia N. Hansel
Nadia N. Hansel Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering Medicine in the USA opens doors to a range of online degrees and healthcare career options. Prospective students who want to start with nursing might benefit from exploring the easiest bsn program to get into, which can help speed up the process of becoming a registered nurse.

For those interested in non-clinical roles, online medical billing and coding with financial aid offers flexibility, affordability, and quick entry into the healthcare field. Many schools now provide accredited programs online, making it easier to balance study with work or other commitments.

If standardized test requirements are a concern, you may consider nursing schools that don't require teas test, which offer alternative pathways to nursing programs.

Plus, students seeking leadership roles in healthcare can look into a healthcare administration online degree to prepare for management positions. These options broaden the scope for anyone pursuing a medical or allied health career in the USA.

Best Scientists Citing Nicola A. Hanania

Trending Scientists

Recently Published Articles